126 related articles for article (PubMed ID: 1080770)
1. Regulatory substances produced by lymphocytes. II. Lymphotoxin in the rat.
Namba Y; Waksman BH
J Immunol; 1975 Oct; 115(4):1018-22. PubMed ID: 1080770
[TBL] [Abstract][Full Text] [Related]
2. Regulatory substances produced by lymphocytes. III. Evidence that lymphotoxin and proliferation inhibitory factor are identical and different from the inhibitor of DNA synthesis.
Namba Y; Waksman BH
J Immunol; 1976 Apr; 116(4):1140-4. PubMed ID: 1082907
[TBL] [Abstract][Full Text] [Related]
3. Relationship of CIF, LT, and PIF released in vitro by activated human lymphocytes. II. A further functional comparison of LT and PIF activities on HeLa and L-929 target cells.
Jeffes EW; Granger GA
J Immunol; 1976 Jul; 117(1):174-9. PubMed ID: 1084364
[TBL] [Abstract][Full Text] [Related]
4. Regulatory factors produced by lymphocytes. II. Inhibition of cellular DNA synthesis associated with a factor inhibiting DNA polymerase alpha activity.
Lee SC; Lucas ZJ
J Immunol; 1977 Jan; 118(1):88-97. PubMed ID: 299764
[TBL] [Abstract][Full Text] [Related]
5. Separation of lymphocyte mitogen from lymphotoxin and experiments on the production of lymphotoxin by lymphoid cells stimulated with the partially purified mitogen: a possible amplification mechanism of cellular immunity and allergy.
Gately CL; Gately MM; Mayer MM
J Immunol; 1976 Mar; 116(3):669-75. PubMed ID: 1082890
[TBL] [Abstract][Full Text] [Related]
6. I. Evidence that lymphotoxin activity involves both cytotoxic and stimulating factors.
Ryzewska AG; Darbrowska BK
Immunology; 1976 Nov; 31(5):677-87. PubMed ID: 136420
[TBL] [Abstract][Full Text] [Related]
7. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
8. Regulatory factors produced by lymphocytes. I. The occurrence of multiple alpha-lymphotoxins associated with ribonuclease activity.
Lee SC; Lucas ZJ
J Immunol; 1976 Jul; 117(1):283-91. PubMed ID: 1084366
[TBL] [Abstract][Full Text] [Related]
9. Relationship of cloning inhibition factor, "lymphotoxin" factor, and proliferation inhibition factor release in vitro by mitogen-activated human lymphoctes.
Jeffes EW; Granger GA
J Immunol; 1975 Jan; 114(1 Pt 1):64-9. PubMed ID: 1078679
[TBL] [Abstract][Full Text] [Related]
10. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
Chiba K; Nishimura T; Hashimoto Y
J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of lymphocytes. VI. Heterogeneity of cytotoxins in supernatants of mitogen-activated lymphocytes.
Walker SM; Lee SC; Lucas ZJ
J Immunol; 1976 Mar; 116(3):807-15. PubMed ID: 1082895
[TBL] [Abstract][Full Text] [Related]
12. The role of lymphotoxin in target cell destruction induced by mitogen-activated human lymphocytes in vitro. II. The correlation of temperature and trypsin-sensitive phases of lymphotoxin-induced and lymphocyte-mediated cytotoxicity.
Kramer SL; Granger GA
J Immunol; 1976 Feb; 116(2):562-7. PubMed ID: 1082459
[TBL] [Abstract][Full Text] [Related]
13. Studies on lymphokines: the production of antibody to guinea pig lymphotoxin and its use to distinguish lymphotoxin from migration inhibitory factor and mitogenic factor.
Gately MK; Gately CL; Henney CS; Mayer MM
J Immunol; 1975 Sep; 115(3):817-26. PubMed ID: 1097529
[TBL] [Abstract][Full Text] [Related]
14. The human LT serum. X. The initial form released by T-enriched lymphocytes is 150,000 m.w., associated with small nonlytic components, and can dissociate into the smaller alpha, beta, and gamma m.w. classes.
Harris PC; Yamamoto RS; Crane J; Granger GA
J Immunol; 1981 Jun; 126(6):2165-70. PubMed ID: 6164723
[TBL] [Abstract][Full Text] [Related]
15. Target cell DNA fragmentation is mediated by lymphotoxin and tumor necrosis factor.
Schmid DS; Hornung R; McGrath KM; Paul N; Ruddle NH
Lymphokine Res; 1987; 6(3):195-202. PubMed ID: 3498099
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
Green LM; Reade JL; Ware CF; Devlin PE; Liang CM; Devlin JJ
J Immunol; 1986 Dec; 137(11):3488-93. PubMed ID: 2431035
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of guinea pig lymphotoxin produced by lymph node cells stimulated by phytohemagglutinin.
Sawada JI; Shioiri-Nakano K; Osawa T
Transplantation; 1975 Apr; 19(4):335-42. PubMed ID: 239474
[TBL] [Abstract][Full Text] [Related]
18. Preparations of lymphotoxin induce resistance to their own cytotoxic effect.
Wallach D
J Immunol; 1984 May; 132(5):2464-9. PubMed ID: 6609199
[TBL] [Abstract][Full Text] [Related]
19. Mouse lymphotoxin.
Trivers G; Braungart D; Leonard EJ
J Immunol; 1976 Jul; 117(1):130-5. PubMed ID: 1084362
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
